{"protocolSection": {"identificationModule": {"nctId": "NCT02097537", "orgStudyIdInfo": {"id": "MC1002"}, "organization": {"fullName": "Santen Pharmaceutical Co., Ltd.", "class": "INDUSTRY"}, "briefTitle": "Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma", "officialTitle": "Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma"}, "statusModule": {"statusVerifiedDate": "2017-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-02"}, "primaryCompletionDateStruct": {"date": "2014-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-03-19", "studyFirstSubmitQcDate": "2014-03-26", "studyFirstPostDateStruct": {"date": "2014-03-27", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-12-20", "resultsFirstSubmitQcDate": "2016-12-20", "resultsFirstPostDateStruct": {"date": "2017-02-14", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-02-27", "lastUpdatePostDateStruct": {"date": "2017-03-29", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Santen Pharmaceutical Co., Ltd.", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation challenge in children with bronchial asthma."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 10, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Methacholine Chloride", "type": "EXPERIMENTAL", "description": "children with bronchial asthma", "interventionNames": ["Drug: Methacholine Chloride (SK-1211)"]}], "interventions": [{"type": "DRUG", "name": "Methacholine Chloride (SK-1211)", "armGroupLabels": ["Methacholine Chloride"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "The Rate of Number of Subjects Whose PC20 is Less Than 8 mg/mL", "description": "The methacholine challenge test is for assessment of bronchial sensitivity, it is assessed by FEV1 (Forced Expiratory Volume in one second) with spirometer.\n\nFor measurement of FEV1, a patient is inhaled saline as baseline and each dose of methacholine which be gradually diluted, inhalations are discontinued with a drop in FEV1 of 20% or more.\n\nThe concentration of methacholine causing 20% fall in FEV1 is PC20.", "timeFrame": "Visit 1 (Day 1)"}], "secondaryOutcomes": [{"measure": "The Rate of Subjects Whose FEV1 Falls More Than 20% From Baseline Before the Highest Concentration Inhalation", "timeFrame": "Visit 1 (Day 1)"}, {"measure": "The Summary Statistics of PC20", "description": "PC20 : the concentration of methacholine causing 20% fall in FEV1.", "timeFrame": "Visit 1 (Day 1)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of bronchial asthma\n* FEV1/FVC must be 70% or more\n* \\<10% decrease in FEV1 in response to inhalation of normal saline\n\nExclusion Criteria:\n\n* Moderate or severe airflow limitation\uff08FEV1\\<60% predicted\uff09\n* Heart attack or stroke in last 3 months\n* Uncontrolled hypertension, systolic BP\\>200, or diastolic BP\\>100\n* known aortic aneurysm", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "15 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"locations": [{"facility": "Santen study sites", "city": "Osaka", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "comment": "Informed consent", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "Enrollment", "achievements": [{"groupId": "FG000", "comment": "Inhalation of Methacholine Chloride", "numSubjects": "10"}]}, {"type": "Follow-Up", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Subjects who have inhaled the investigational drug at least once.", "groups": [{"id": "BG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "10"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "10"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "10.7", "spread": "2.4"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "6"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Japan", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "The Rate of Number of Subjects Whose PC20 is Less Than 8 mg/mL", "description": "The methacholine challenge test is for assessment of bronchial sensitivity, it is assessed by FEV1 (Forced Expiratory Volume in one second) with spirometer.\n\nFor measurement of FEV1, a patient is inhaled saline as baseline and each dose of methacholine which be gradually diluted, inhalations are discontinued with a drop in FEV1 of 20% or more.\n\nThe concentration of methacholine causing 20% fall in FEV1 is PC20.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of the subjects", "timeFrame": "Visit 1 (Day 1)", "groups": [{"id": "OG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7"}]}]}]}, {"type": "SECONDARY", "title": "The Rate of Subjects Whose FEV1 Falls More Than 20% From Baseline Before the Highest Concentration Inhalation", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of the subjects", "timeFrame": "Visit 1 (Day 1)", "groups": [{"id": "OG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7"}]}]}]}, {"type": "SECONDARY", "title": "The Summary Statistics of PC20", "description": "PC20 : the concentration of methacholine causing 20% fall in FEV1.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/mL", "timeFrame": "Visit 1 (Day 1)", "groups": [{"id": "OG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8.0674", "spread": "11.7127"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Visit 1 (Day 1)", "eventGroups": [{"id": "EG000", "title": "Methacholine Chloride", "description": "children with bronchial asthma\n\nMethacholine Chloride (SK-1211)", "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 7, "otherNumAtRisk": 10}], "otherEvents": [{"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA/J ver.17.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 10}]}, {"term": "Choking sensation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA/J ver.17.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 10}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA/J ver.17.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 10}]}, {"term": "Breath sounds abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA/J ver.17.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 10}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "General Manager of Clinical Development Group", "organization": "Santen Pharmaceutical Co., Ltd.", "email": "clinical@santen.co.jp"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000016210", "term": "Methacholine Chloride"}], "ancestors": [{"id": "D000008916", "term": "Miotics"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000010277", "term": "Parasympathomimetics"}, {"id": "D000016085", "term": "Bronchoconstrictor Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000018721", "term": "Muscarinic Agonists"}, {"id": "D000018679", "term": "Cholinergic Agonists"}, {"id": "D000018678", "term": "Cholinergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M18666", "name": "Methacholine Chloride", "asFound": "Female Sex", "relevance": "HIGH"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M20795", "name": "Muscarinic Agonists", "relevance": "LOW"}, {"id": "M20758", "name": "Cholinergic Agents", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}